|Bid||1.71 x 100|
|Ask||1.90 x 1500|
|Day's Range||1.71 - 1.79|
|52 Week Range||1.71 - 10.90|
|PE Ratio (TTM)||-0.42|
|Earnings Date||May 12, 2017 - May 15, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
BERKELEY HEIGHTS, N.J., July 21, 2017-- Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using cell cycle, transcriptional regulation and DNA damage response biology to develop ...
NEW YORK, NY / ACCESSWIRE / July 20, 2017 / U.S. markets reached new record highs Wednesday as better-than-expected earnings from Morgan Stanley helped to strengthen investor optimism for the current earnings ...
Q1 2017 Cyclacel Pharmaceuticals Inc Earnings Call